SPONSORED CONTENT
Let me start by saying that I have been to the 340B Coalition conferences since 2012, and every year entities have feared significant changes and the threat of problematic legislation becoming law. Fortunately,
…SPONSORED CONTENT
Let me start by saying that I have been to the 340B Coalition conferences since 2012, and every year entities have feared significant changes and the threat of problematic legislation becoming law. Fortunately,
…SPONSORED CONTENT
The 340B program serves as a critical resource for hospitals and other safety net providers striving to provide comprehensive care to their patient populations. However, evolving operational requirements make it essential for covered entities to develop programs that are both scalable and
…SPONSORED CONTENT
The 340B Drug Pricing Program is at a crossroads, facing increased scrutiny, manufacturer restrictions, and ongoing legal battles. In this must-watch webinar, industry experts Ted Slafsky (340B Report), Emily Cook (McDermott, Will & Emery), and Nicole Shoquist (JPS Health Network) break down the
…SPONSORED CONTENT
The healthcare landscape is evolving rapidly, and with it, the need for stronger, smarter partnerships has never been greater. Covered entities are navigating a time of uncertainty, where operational challenges, regulatory scrutiny, and resource constraints are putting unprecedented pressure on healthcare organizations. That’s why
…SPONSORED CONTENT
Artificial Intelligence (AI) has become a buzzword in nearly every industry, but
…SPONSORED CONTENT
Date/Time: Monday, February 24 from 8:30-9:30AM PST
Location: Marina Ballroom D @ the Marriott Marquis (3rd Floor, South Tower)
Start your week at the 340B Coalition Winter Conference ’25 with the latest developments in the 340B
…SPONSORED CONTENT
The healthcare system is undergoing a major transformation, with a growing emphasis on value-based care and outcomes-based payment models. These shifts aim to improve patient outcomes and reduce costs, fundamentally challenging traditional fee-for-service approaches. Against this backdrop, the 340B
…SPONSORED CONTENT
The evolving landscape of pharmaceutical pricing and reimbursement models presents complex challenges for manufacturers and pharmacies. One of the most significant developments is the introduction of the Inflation Reduction Act (IRA) and its Maximum Fair Price (MFP) provisions, aimed at reducing drug
…SPONSORED CONTENT
It’s January, which means we’ve released our Top Ten Issues for 2025! The experts at Visante have provided insights into the most pressing issues and transformative opportunities in health system pharmacy for the
…*Sign up for news summaries and alerts from 340B Report